These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23325993)
1. Enhanced Controlled Transdermal Delivery of Ambroxol from the EVA Matrix. Cho CW; Kim DB; Cho HW; Shin SC Indian J Pharm Sci; 2012 Mar; 74(2):127-32. PubMed ID: 23325993 [TBL] [Abstract][Full Text] [Related]
2. Enhanced Controlled Transdermal Delivery of Mexazolam Using Ethylene-vinyl Acetate. Weon Cho C; Chul Shin S Iran J Pharm Res; 2012; 11(1):3-12. PubMed ID: 25317180 [TBL] [Abstract][Full Text] [Related]
3. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix. Cho CW; Choi JS; Yang KH; Shin SC Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946 [TBL] [Abstract][Full Text] [Related]
4. Development of the ambroxol gels for enhanced transdermal delivery. Cho CW; Choi JS; Shin SC Drug Dev Ind Pharm; 2008 Mar; 34(3):330-5. PubMed ID: 18363149 [TBL] [Abstract][Full Text] [Related]
5. Development and biopharmaceutical evaluation of quinupramine-EVA matrix containing penetration enhancer for the enhanced transdermal absorption in rats. Shin SC; Kim J; Kim WJ; Kim SJ; Cho CW Pharm Dev Technol; 2007; 12(5):429-36. PubMed ID: 17963142 [TBL] [Abstract][Full Text] [Related]
6. Enhanced transdermal delivery of loratadine from the EVA matrix. Cho CW; Choi JS; Kim SJ; Shin SC Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983 [TBL] [Abstract][Full Text] [Related]
7. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats. Cho CW; Choi JS; Yang KH; Shin SC Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890 [TBL] [Abstract][Full Text] [Related]
8. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats. Shin SC; Choi JS Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195 [TBL] [Abstract][Full Text] [Related]
9. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix. Cho CW; Shin SC Int J Pharm; 2004 Dec; 287(1-2):67-71. PubMed ID: 15541913 [TBL] [Abstract][Full Text] [Related]
10. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer. Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619 [TBL] [Abstract][Full Text] [Related]
11. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix. Shin SC; Lee HJ Eur J Pharm Biopharm; 2002 Nov; 54(3):325-8. PubMed ID: 12445563 [TBL] [Abstract][Full Text] [Related]
12. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix. Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151 [TBL] [Abstract][Full Text] [Related]
13. Development of bioadhesive transdermal bupivacaine gels for enhanced local anesthetic action. Cho CW; Kim DB; Shin SC Iran J Pharm Res; 2012; 11(2):423-31. PubMed ID: 24250466 [TBL] [Abstract][Full Text] [Related]
14. Controlled release of furosemide from the ethylene-vinyl acetate matrix. Cho CW; Choi JS; Shin SC Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605 [TBL] [Abstract][Full Text] [Related]
15. Enhanced local anesthetic action of mepivacaine from the bioadhesive gels. Cho CW; Choi JS; Shin SC Pak J Pharm Sci; 2011 Jan; 24(1):87-93. PubMed ID: 21190925 [TBL] [Abstract][Full Text] [Related]
16. Enhanced transdermal delivery of pranoprofen from the bioadhesive gels. Shin SC; Cho CW Arch Pharm Res; 2006 Oct; 29(10):928-33. PubMed ID: 17121190 [TBL] [Abstract][Full Text] [Related]
17. Controlled release of pranoprofen from the ethylene-vinyl acetate matrix using plasticizer. Cho CW; Choi JS; Shin SC Drug Dev Ind Pharm; 2007 Jul; 33(7):747-53. PubMed ID: 17654023 [TBL] [Abstract][Full Text] [Related]
18. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems. Shin SC; Lee HJ Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692 [TBL] [Abstract][Full Text] [Related]
19. Development of the loratadine gel for enhanced transdermal delivery. Song JH; Shin SC Drug Dev Ind Pharm; 2009 Aug; 35(8):897-903. PubMed ID: 19241201 [TBL] [Abstract][Full Text] [Related]
20. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement. Aboofazeli R; Zia H; Needham TE Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]